Yossi Maimon
VP, Chief Financial Officer at PLX
- Sold, on record
- $4.1M
- Dollars the filings state
- Form 4 sales
- 8
- Latest May 2, 2012
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- PLXProtalix BioTherapeutics, Inc.VP, Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
8
Unusual
Form 4 sales per year, every sale on record.
Timeline
- May 2, 2012Unusual
Sold 100% of their holdings
$898k125,964 shares at $7.13
- Oct 7, 2010Unusual
Sold 100% of their holdings
$677k70,000 shares at $9.67
- Sep 7, 2010Unusual
Sold 100% of their holdings
$565k70,000 shares at $8.07
- Oct 16, 2009Unusual
Sold 100% of their holdings
$1.4M150,000 shares at $9.46
- Jul 7, 2009Unusual
Sold 100% of their holdings
$255k50,000 shares at $5.11
- May 18, 2009Unusual
Sold 100% of their holdings
$120k30,000 shares at $4.00
- Mar 13, 2009Unusual
Sold 100% of their holdings
$109k48,590 shares at $2.24
- Feb 25, 2008Unusual
Sold 55.5% of their holdings
$106k33,300 shares at $3.18
8 of 8
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | Jan 23, 2023 | Ayala Pharmaceuticals, Inc. | CFO, Secretary and Treasurer | Returned to the companyStock Option (right to buy) | 131,080 | 0 | SEC | ||
| Jan 19, 2023 | Jan 23, 2023 | Ayala Pharmaceuticals, Inc. | CFO, Secretary and Treasurer | Returned to the company | 69,872 | 0 | SEC | ||
| May 16, 2022 | May 16, 2022 | Ayala Pharmaceuticals, Inc. | CFO, Secretary & Treasurer | Awarded | 50,000 | 69,872 | SEC | ||
| Jan 3, 2022 | Jan 5, 2022 | Ayala Pharmaceuticals, Inc. | CFO, Secretary & Treasurer | AwardedStock Option | 31,950 | 31,950 | SEC | ||
| Jan 4, 2021 | Jan 6, 2021 | Ayala Pharmaceuticals, Inc. | CFO, Secretary & Treasurer | AwardedStock Option | 19,170 | 19,170 | SEC | ||
| Jan 4, 2021 | Jan 6, 2021 | Ayala Pharmaceuticals, Inc. | CFO, Secretary & Treasurer | Awarded | 8,520 | 19,872 | SEC | ||
| May 7, 2020 | May 11, 2020 | Ayala Pharmaceuticals, Inc. | CFO, Secretary & Treasurer | Awarded | 11,352 | 11,352 | SEC | ||
| Sep 13, 2018 | Sep 14, 2018 | PLX | VP, Chief Financial Officer | AwardedStock Options (Right to Buy) | 700,000 | 700,000 | SEC | ||
| Dec 14, 2015 | Dec 15, 2015 | PLX | Vice President & CFO | Bought | 10,000 | $0.78 | $8k | 10,000 | SEC |
| Mar 23, 2015 | May 7, 2015 | PLX | VP, Chief Financial Officer | AwardedStock Options (Right to Buy) | 250,000 | 250,000 | SEC | ||
| Jul 16, 2012 | Jul 18, 2012 | PLX | Vice President & CFO | Awarded | 185,000 | 185,000 | SEC | ||
| May 2, 2012 | May 4, 2012 | PLX | VP, Chief Financial Officer | Sold | 125,964 | $7.13 | $898k | 0 | SEC |
| May 2, 2012 | May 4, 2012 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 125,964 | 0 | SEC | ||
| May 2, 2012 | May 4, 2012 | PLX | VP, Chief Financial Officer | Exercised options | 125,964 | $1.64 | $206k | 125,964 | SEC |
| Oct 7, 2010 | Oct 8, 2010 | PLX | VP, Chief Financial Officer | Sold | 70,000 | $9.67 | $677k | 0 | SEC |
| Oct 7, 2010 | Oct 8, 2010 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 77,769 | 75,964 | SEC | ||
| Oct 7, 2010 | Oct 8, 2010 | PLX | VP, Chief Financial Officer | Exercised options | 77,769 | $0.97 | $75k | 0 | SEC |
| Oct 7, 2010 | Oct 8, 2010 | PLX | VP, Chief Financial Officer | Withheld for tax | 7,769 | $9.73 | $76k | 0 | SEC |
| Sep 7, 2010 | Sep 8, 2010 | PLX | VP, Chief Financial Officer | Sold | 70,000 | $8.07 | $565k | 0 | SEC |
| Sep 7, 2010 | Sep 8, 2010 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 70,000 | 153,733 | SEC | ||
| Sep 7, 2010 | Sep 8, 2010 | PLX | VP, Chief Financial Officer | Exercised options | 70,000 | $0.97 | $68k | 0 | SEC |
| Feb 25, 2010 | Feb 26, 2010 | PLX | VP, Chief Financial Officer | AwardedStock Options (Right to Buy) | 130,000 | 130,000 | SEC | ||
| Oct 16, 2009 | Oct 19, 2009 | PLX | VP, Chief Financial Officer | Sold | 150,000 | $9.46 | $1.4M | 0 | SEC |
| Oct 16, 2009 | Oct 19, 2009 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 167,698 | 223,733 | SEC | ||
| Oct 16, 2009 | Oct 19, 2009 | PLX | VP, Chief Financial Officer | Exercised options | 167,698 | $0.97 | $163k | 0 | SEC |
| Oct 16, 2009 | Oct 19, 2009 | PLX | VP, Chief Financial Officer | Withheld for tax | 17,698 | $9.21 | $163k | 0 | SEC |
| Jul 7, 2009 | Jul 8, 2009 | PLX | VP, Chief Financial Officer | Sold | 50,000 | $5.11 | $255k | 0 | SEC |
| Jul 7, 2009 | Jul 8, 2009 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 62,217 | 391,431 | SEC | ||
| Jul 7, 2009 | Jul 8, 2009 | PLX | VP, Chief Financial Officer | Exercised options | 62,217 | $0.97 | $60k | 0 | SEC |
| Jul 7, 2009 | Jul 8, 2009 | PLX | VP, Chief Financial Officer | Withheld for tax | 12,217 | $4.95 | $60k | 0 | SEC |
| May 18, 2009 | May 19, 2009 | PLX | VP, Chief Financial Officer | Sold | 30,000 | $4.00 | $120k | 0 | SEC |
| May 18, 2009 | May 19, 2009 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 40,348 | 453,648 | SEC | ||
| May 18, 2009 | May 19, 2009 | PLX | VP, Chief Financial Officer | Exercised options | 40,348 | $0.97 | $39k | 40,348 | SEC |
| May 18, 2009 | May 19, 2009 | PLX | VP, Chief Financial Officer | Withheld for tax | 10,348 | $3.79 | $39k | 30,000 | SEC |
| Mar 13, 2009 | Mar 13, 2009 | PLX | VP, Chief Financial Officer | Sold | 48,590 | $2.24 | $109k | 0 | SEC |
| Mar 13, 2009 | Mar 13, 2009 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 39,800 | 493,996 | SEC | ||
| Mar 13, 2009 | Mar 13, 2009 | PLX | VP, Chief Financial Officer | Exercised options | 39,800 | $0.97 | $39k | 0 | SEC |
| Mar 13, 2009 | Mar 13, 2009 | PLX | VP, Chief Financial Officer | Withheld for tax | 17,910 | $2.16 | $39k | 0 | SEC |
| Feb 25, 2009 | Feb 27, 2009 | PLX | VP, Chief Financial Officer | AwardedStock Options (Right to Buy) | 50,000 | 50,000 | SEC | ||
| Feb 25, 2008 | Feb 26, 2008 | PLX | VP, Chief Financial Officer | Sold | 33,300 | $3.18 | $106k | 26,700 | SEC |
| Feb 22, 2008 | Feb 26, 2008 | PLX | VP, Chief Financial Officer | Exercised or settledStock Options (Right to Buy) | 86,176 | 533,796 | SEC | ||
| Feb 22, 2008 | Feb 26, 2008 | PLX | VP, Chief Financial Officer | Exercised options | 86,176 | $0.97 | $84k | 86,176 | SEC |
| Feb 22, 2008 | Feb 26, 2008 | PLX | VP, Chief Financial Officer | Withheld for tax | 26,176 | $3.20 | $84k | 60,000 | SEC |
| Feb 7, 2008 | Feb 13, 2008 | PLX | VP, Chief Financial Officer | AwardedStock Options (Right to Buy) | 175,000 | 175,000 | SEC | ||
| Dec 31, 2006 | Jan 5, 2007 | PLX | VP, Chief Financial Officer | AwardedStock Options (Right to Buy) | 619,972 | 619,972 | SEC |
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2012 | May 4, 2012 | PLX | VP, Chief Financial Officer | Form 4 sale | 125,964 | $898k | 100.0% | Unusual | SEC |
| Oct 7, 2010 | Oct 8, 2010 | PLX | VP, Chief Financial Officer | Form 4 sale | 70,000 | $677k | 100.0% | Unusual | SEC |
| Sep 7, 2010 | Sep 8, 2010 | PLX | VP, Chief Financial Officer | Form 4 sale | 70,000 | $565k | 100.0% | Unusual | SEC |
| Oct 16, 2009 | Oct 19, 2009 | PLX | VP, Chief Financial Officer | Form 4 sale | 150,000 | $1.4M | 100.0% | Unusual | SEC |
| Jul 7, 2009 | Jul 8, 2009 | PLX | VP, Chief Financial Officer | Form 4 sale | 50,000 | $255k | 100.0% | Unusual | SEC |
| May 18, 2009 | May 19, 2009 | PLX | VP, Chief Financial Officer | Form 4 sale | 30,000 | $120k | 100.0% | Unusual | SEC |
| Mar 13, 2009 | Mar 13, 2009 | PLX | VP, Chief Financial Officer | Form 4 sale | 48,590 | $109k | 100.0% | Unusual | SEC |
| Feb 25, 2008 | Feb 26, 2008 | PLX | VP, Chief Financial Officer | Form 4 sale | 33,300 | $106k | 55.5% | Unusual | SEC |